AMD and DME: Highlighting the Role of the Pharmacist in Patient Education and Counseling

This activity is part 3 in a 3-part webinar curriculum and includes pharmacist counseling vignettes.

Program Description

Specialty pharmacists should properly educate and counsel patients with age-related macular degeneration/diabetic macular edema (AMD/DME) about the importance of treatment adherence. Strategies, such as education and counseling on the risks of AMD and therapeutic options available, implemented by pharmacists can equip patients with the knowledge necessary to make informed decisions regarding their care. Pharmacists are in a unique position to ensure a reduction in treatment-related burdens and optimization of treatment through personalized recommendations and individualized care, effectively improving adherence and access to therapies. This third webinar of the curriculum will discuss the impact of patient education and counseling on AMD/DME treatment and management.

Target audience: Specialty pharmacists

Type of activity: Application
Release date: September 6, 2023
Expiration date: November 6, 2023

Time to complete activity: 1.0 hour

Learner level: Foundational, intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify the role of the pharmacist in patient education regarding age-related macular degeneration/diabetic macular edema and the available treatment therapies
• Explore approaches to improve patient adherence and optimize patient quality of life
• Determine strategies and opportunities for pharmacists to provide personalized recommendations to improve access to anti-vascular endothelial growth factor therapies and improve patient outcomes

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-23-324-L01-P. The activity is available for CE credit through November 6, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Alan Pannier, PharmD, MBA

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Michelle C. Carlson, PharmD; Rose Namissa-Buszka, PharmD, BCPS, CHCP; Abigail Dill, Susan Pordon; Brianna Winters; and Chloe Taccetta

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms